According to Edward Dowd, an alleged fraudulent paper was submitted to discredit an available COVID-19 treatment, potentially influencing the Emergency Use Authorization (EUA) for mRNA COVID-19 vaccines. This has implications for trading as EUAs cannot be issued if effective treatments are available, which could affect vaccine-related stocks and market dynamics. The situation suggests possible intent and forethought of a conspiracy, impacting investor confidence and market stability. Source: Edward Dowd.